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Abstract: The mortality of Acute Respiratory Dis-
tress Syndrome (ARDS) is still high from 27 to 45% ac-
cording to Berlin definition. Even in surgical patients
without lung injury, the postoperative pulmonary com-
plications (PPCs) are frequent. Mechanisms of ARDS,
ventilator associated lung injury (VALI) and PPCs are
better understood. In ARDS, protective ventilation with
lowtidalvolume6ml/kgPBWandhigherlevelsofpos-
itive end-expiratory pressure (PEEP) is widely accepted
as routine practice. In no ARDS patients undergoing
mechanical ventilation, protective ventilation with low
tidalvolume6ml/kgPBWandlowtomoderatelevelsof
PEEP has become the new challenge paradigm shift of
supportive care mainly in ICU and perioperative pa-
tients. Respiratory monitoring is very helpful for opti-
mizing mechanical ventilator setting to prevent VALI
and early detect PPCs during the perioperative period.
Several scores have been developed to stratify the risk
ofARDS,VALIandPPCs.It’stimetoapplybasicphys-
iologic knowledge of respiratory function and evidence
based practice to improve ARDS and PPCs outcomes.
Key words: Ventilator-Associated Lung Injury,
Acute Respiratory Distress Syndrome, Transpulmonary
pressure, Positive End Expiratory Pressure, Protective
ventilation, Respiratory monitoring.
INTRODUCTION
Using the original American-European Consen-
sus Conference (AECC) definition of the Acute Respi-
ratory Distress Syndrome (ARDS), the incidence of
ARDS was vary from 5–33.8 cases per 100,000 popu-
lations (1). Several studies have shown the improve-
ment of outcome in selected groups of ARDS and the
ARDS related mortality was gradually decreased from
70% to 40% in the last decades.
According to the limitations of AECC definition
ofARDSi.e.thedecrease inusageofSwan-Ganzcath-
eter to distinguish the presence of hydrostatic edema
and poor sensitivity of PaO2/FiO2 ratio in different
levels of positive end expiratory pressure (PEEP), the
Berlin definition has been developed in order to yield
better predictability for mortality than AECC defini-
tion, to be easily for clinical research implementation
as well as to exclude the term acute lung injury for
avoiding possible misinterpretation (2). Recent studies
have demonstrated that various severities of ARDSac-
cording to Berlin definition are associated with the de-
greeextravascular lung waterindex, pulmonary vascu-
lar permeability index by using transpulmonary ther-
modilutionmethod(3)andthefindingofdiffusealveo-
lar damage at autopsy (4, 5). The mortality of ARDS is
still high from mild to severe as 27 to 45% by Berlin
definition (2).
Not only ARDS but also pulmonary complicati-
ons particularly during perioperative period and in in-
tensive care unit (ICU) with previously non-injured
lung became an interesting issue. Arecent, large Euro-
pean cohort study involving 46,539 patients who un-
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ably high mortality as 4% (6) which may resulted from
the high incidence of postoperative pulmonary compli-
cations (PPCs) (7). The incidence of PPCs varies accor-
ding to the definitions of each study. PPCs were classi-
fied as respiratory failure from pulmonary or cardiac or-
igin, pneumonia, respiratory infection, pleural effusion,
atelectasis, pneumothorax, bronchospasm, need of
non-invasive respiratory support and re-intubation as
well as mortality. These complications are associated
with underlying status, types of surgery or anaesthesia
as well as the mechanical ventilator settings (7).
Severalstudieshaveshownthatmechanicalventi-
lation (MV) not only preserves the life but can aggra-
vate ventilator associated lung injury (VALI). Recent
studies have focused on the new strategies for treat-
ment and prevention of ARDS and VALI (8, 9, 10).
InARDS,protective ventilation isnow widely ac-
cepted as the routine practice. In non-ARDS patients
with MV, protective ventilation has become the new
challenge paradigm shift of supportive care mainly in
ICU and perioperative patients as well as heart beating
organdonors(11).Inthisarticle,weaimtodescribe:1)
the pathophysiology of ventilator associated lung in-
jury in ARDS and the PPCs in non ARDS patients; 2)
the bedside respiratory monitoring tools; 3) the recent
evidence of protective ventilator strategies in both
ARDS and non ARDS patients as well as adjunctive
therapies; and 4) the predictive scores of ARDS, VALI
and postoperative pulmonary complications.
1. Mechanisms of ventilator associated
lung injury and postoperative
pulmonary complications
1.1 Atelectrauma, volume trauma,
barotrauma
Ventilation at high lung volume has been shown
yielding to alveolar rupture and barotrauma. Several
experimental studies have demonstrated that the high
MV pressure setting induces rupture of air space not
fromtheabsolutepressureitself,butfromthedegreeof
lung over distension. Thus, the end inspiratory plateau
and tidal volume (VT)perideal body weight areinade-
quate parameters to determine the real lung stress and
strain. The major determinants of VALI are lung stress
ordistending force(depend ontheapplied transpulmo-
nary pressure ŠPL¹)greater than 20–24 cm H2Oduring
inspiration and lung strain defined by the proportion of
applied tidal volume plus inflated lung volume due to
PEEP application and the resting lung volume (functi-
onal residual capacity) greater than 1.5–2 (12, 13).
Even in healthy lung, experimental study suggested
that long term high tidal volume ventilation with lung
strain of 2.5 caused the animals died from respiratory
failure (14). If the lungs are inhomogeneous, the ap-
plied force will mainly stress on the regions around
collapsed and consolidated part which joining to those
of opened part. This leads to the increase in stress and
strain at wall of opening alveoli particularly in higher
alveolar volume (pressure multipliers or lung stress ra-
iser) (12). Lung inhomogeneity is associated with ove-
rall mortality and severity of ARDS (12).
During ventilation at low lung volume, repetitive
tidal-cyclic opening and closing of alveoli and distal
airwayleads toshearstresssocalled atelectrauma. The
surfactant dysfunction results in airway collapse hence
atelectraumabytheforcethatgeneratedbysurfaceten-
sion and consequence to an increase of stress and
strain. The maneuver which aiming to decrease the
lung inhomogeneity such as higher PEEP improved
oxygenation and tended to decrease in mortality (15).
In addition to mechanisms associated with VALI,
others mechanisms producing PPCs are: 1) general an-
esthesia, sedation andmuscleparalysis caused areduc-
tion of respiratory muscle tone, oxygen reabsorption
lead to an increase in atelectasis as well as peripheral
airway closure; 2) reduction of functional residual ca-
pacity; 3) altering of diaphragmatic position (cephalic
shift of diaphragm); 4) redistribution of thoracic blood
volume and 6) surfactant inactivation.
1.2 Biotrauma
Lung cells have mechanisms that allow them to
deal with physiological deformations during normal
breathing. Nevertheless, under mechanical ventilation,
such forces might be excessive and lead to cell injury.
The concept of biotrauma arised in the early 1990s,
when several experiments revealed the existence of a
relevant biological response to mechanical forces (16,
17). Biotrauma involves the local release of inflamma-
tory mediators that reach the systemic circulation spre-
ading the damage, an excessive activation of the im-
mune system, as well as other numerous cellular re-
sponses triggered by mechanical forces (18). The nu-
merous effects of these multiple biological responses
greatly account for the high mortality of patients with
lung injury and ARDS from multiple organ dysfunc-
tion syndrome (19).
1.2.1 Effects on alveolar epithelium,
endothelium and extracellular
matrix
The force derived from mechanical ventilation
andoverinflationinvolvearearrangementofthecellu-
lar shape of alveolar cells, types I or II, and endotheli-
um. In this context, cytoskeleton plays a crucial role,
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nical forces into biochemical responses (mechanotran-
sduction).Cytoskeletalreorganization,integrinsandion
channels are major players of this process, activating a
complex network of intracellular pathways that eventu-
ally result in extracellular matrix remodelling, recruit-
ment of white cells, and cytokine release (18, 20). If
stress and strain reach the limit of rupture of the fibre
system, mechanical failure may occur with direct ruptu-
re of alveolar walls and pulmonary capillaries (19).
Toll-likereceptors(TLRs)areinnateimmunesen-
sors expressed by a range of immune cells, and also by
epithelial cells (21). TLRs activate the transcription
factor nuclear factor kappa B (NF-kappaB), which even-
tually results in an increased expression of inflamma-
tory genes. The activation of NF-kappaB, which has
been established in VALI (22), induces the production
of inflammatory mediators like tumor necrosis factor
(TNF) alpha, interleukins (IL) 6, IL-8 or IL-1â (19),
which,amongothers,haveshowntobeimportantly in-
volved in the pathophysiology of VALI (23, 24). Im-
portantly, cytokines and chemokines released by epit-
helial cells and alveolar macrophages induce therecru-
itment of neutrophils to the lung via IL-8 (19), which
amplify tissue inflammation.
Molecules that constitute the extracellular matrix
(ECM), such as hyaluronan, biglycan, versican, hepa-
ran sulfate, fibronectin ortenascin-C are important ac-
tivators ofTLRs(25,26).Thesemolecules have essen-
tial functions in many lung pathophysiological proces-
ses, as they regulate tissue hydration, macromolecular
structure and function, response to inflammatory
agents, and tissue repair (27). Current evidence shows
that mechanical ventilation, not only at injurious but
also at physiologic tidal volume, may deeply affect
ECM structure and function (28, 29). In this context,
ECMmodifications mayinfluence thealteredmechan-
ical behavior of the lung parenchyma and also contrib-
ute to the subsequent inflammatory events, since ECM
constituentsareamongTLRendogenousligands(27).
Oxidative stress is another important mechanism
during biotrauma. Evidence from animal models sug-
gests that oxidative stress and redox imbalance contri-
bute to enhance/perpetuate susceptibility to VALI (30,
31). Lung alveolar and epithelial cells have showed an
increase on reactive oxygen species production in re-
sponse to elevated stretch (32). Elevated oxidant relea-
se in serum as well as decreased lung glutathione, the
major antioxidant in the lung, were observed in rats
ventilated at high tidal volume (20 mL/kg) (33). An in-
creased superoxide production has been observed in
ventilated patients (34) and, importantly, antioxidant
strategies have shown beneficial effects in experimen-
tal models both atthe local and systemic levels, attenu-
ating VALI-associated inflammation, apoptosis and
oxidative responses (35, 36).
Mechanisms of inflammation, ECM disruption or
oxidative stress are, to a greater or lesser extent, even-
tually associated withcelldeath. VALIhasbeenshown
toinduce apoptosis ofairwayepithelial cells(37).Inte-
restingly, experimental studies showed that hydrogen
inhalation as a therapeutic approach provided cytopro-
tective effects against apoptotic and inflammatory sig-
naling pathway activation during VALI (36, 38).
1.2.2 Mechanisms of repair
Membrane disruption acts as a mechanotransdu-
cer, whereby the influx of calcium after membrane in-
jury leads to the up regulation of mediators as and
NF-kappaB. Deformation-induced plasma membrane
disruptions have been directly linked to the activation
of pro-inflammatory signaling cascades including
early stress response genes, chemokine receptors, and
adhesion molecules regulation. Plasma membrane ho-
meostasis isadynamic process, and deformation-indu-
ced lipid trafficking is an important cytoprotective
mechanism employed by the cell in the face of exter-
nally imposed shape change. The balance of these pat-
hways may be influenced by certain conditions that
shift the equilibrium towards the favoring of either a
pro-injury or pro-repair state (39).
Processes of re-epithelization and collagen degra-
dation are essential in lung repair, and inflammatory
cells can modulate both ECM degradation and epithe-
lial cell migration through different mechanisms (40):
release of proteases that cleave collagen, gelatin, and
elastin; modulation of inflammation toward an anti-in-
flammatory response; and by directly releasing growth
factors that stimulate epithelial cell migration and pro-
liferation (41). González-López et al. have demon-
stratedthatsomeofthesephenomena takeplaceduring
the repair phase after VALI, concluding that an ade-
quateinflammatory responseandECMremodeling are
essential for recovery (42). However, ECM degrada-
tion and remodeling are complex mechanisms. If in-
flammation of pro-fibrotic responses are exaggerated
and unbalanced, the process can lead to fibrosis and
organ failure (43).
Apart from repair focused on inflammation or
ECM,newapproaches areemerging.Inthissense,sev-
eral studies have shown promising results using
mesenchymal stem cells, which have shown beneficial
results, reducing VALI in animal models (44, 45, 46).
1.2.3 Biomarkers for VALI
The majority of biological markers identified in pla-
sma, serum, pulmonary edema fluid, and bronchoal-
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chemokines. None of them distinguishes VALI from
other etiologies of lung injury. However, the temporal
association between changes in levels of these proteins
and changes in tidal volume or PEEP suggests a caus-
ative role (47).
The study of a panel of biomarkers has shown su-
perior performance to single biomarkers. Abnormal
levels of five biomarkers in plasma provided excellent
discrimination for diagnosis of ARDS in patients with
severe sepsis, being three of them generated by lung
epithelium (48). Interestingly, a recent study has found
that VALI is characterized by a particular metabolic
profile that suggests alterations in energy and mem-
brane lipids (49).
Although the definition ofARDSisbased on clin-
ical criteria, altered levels of plasma biomarkers may
be useful to assist in confirming the diagnosis in cer-
tain cases, to categorize them, to facilitate selection for
clinical trials as well as a valuable tool for identifying
patients atrisk,determining prognosis andunderstand-
ing pathogenesis (47).
2. Respiratory monitoring
2.1 Respiratory mechanics
and Esophageal pressure
measurement
Generally we can monitor patients receiving MV
byobservingstaticairwaypressure,measuringrespira-
tory system compliance and analyzing dynamic pres-
sure-volume curve. Terragni et al assessed the accu-
racy of plateau pressure and stress index to identify the
point associated with injurious ventilation. This study
demonstrated that plateau pressure (Pplat) more than
25 cm H2O and stress index more than 1.05 have been
shown the best performance to define the injurious
ventilation (50). In terms of lung strain, the reference
value computed by the ventilator is still controversial.
Furthermore, the reference volume atFunctional resid-
ual capacity (FRC) is the lung volume at zero PEEPle-
vel and should be at resting lung (pre-stressed condi-
tion) (12). Some studies have proposed the reference
volume should be the end expiratory lung volume dur-
ing PEEPapplication, which considered as continuous
strain (12).
The proportion of airway pressure is contributed
by the elastance of chest wall. Some conditions that in-
crease chest wall elastance i.e. obesity, abdominal sur-
gery,intra-abdominal hypertension, pleural effusion or
even ARDS (H1N1 associated ARDS) make the air-
way pressure not representing the real stress and strain
of the lungs (51, 52). MV setting guided by transpul-
monary pressure, not airway pressure, and intraabdo-
minal pressure monitoring can promote appropriate al-
veolar recruitment and avoid lung hyperinflation and
may prevent further pulmonary complications. In
spontaneous breathing patients, during postoperative
period, beside pulse oximetry (53) and capnography,
esophageal pressure(Peso)canbeusedtomonitor sed-
ative drugs usage, patients-ventilator asynchrony and
intrinsic PEEP during weaning from MV in high risk
PPCs patients, i.e. COPD patients (52, 54).
Talmor et al. have demonstrated the value of Peso
guiding for appropriate PEEP levels in ARDS patients
to achieve better oxygenation at 72 hours compared
with MV setting based on PEEP-FiO2 table according
to ARDSNetwork. At end expiration, PEEPcan be ad-
justed until the PLbecome positive and should not ex-
ceed 10 cm H2O to keep airway opening and avoid
overstretch. At end inspiration, set tidal volume are li-
mited to keep PLless than 25 cm H2O (12, 55). Howe-
ver, some authors have debated using the absolute
pressure and preferred using the variation of the Peso
rather than the absolute value to estimate lung stress
namely elastance derived method calculating chest
wall elastance (Ecw) which is the ratio of Pressure dif-
ferenceacrosschestwall(Pcw)/VT.Understaticcon-
dition, PL = Paw x (EL/ERS) in which EL = PL/VT and
ERS = Paw/VT (52). Peso can distinguish the fraction
of airway pressure that overcome lung or chest wall
elastance.
2.2 Ultrasound in ICU
and Perioperative period
In ARDS, the presence of pulmonary vascular
dysfunction and extravascular lung water are associa-
ted with higher mortality (56). Although some meth-
ods, i.e. pulse pattern analysis and transpulmonary
thermodilution technique can provide the hemodyna-
mic goal directed therapy and respiratory variables as
well as extravascular lung water (EVLW) index in eit-
her ICU or high risk surgical patients. Nevertheless,
these techniques are invasive. Regarding the availabil-
ity and noninvasiveness of bedside ultrasound and ec-
hocardiography, lung ultrasound can estimate EVLW
index and evaluate the response of PEEP titration in
ARDS (57). Jambrik et al. have demonstrated that the-
re is significant correlation between numbers of B-li-
nes (58) and wet to dry ratio measured by gravimetric
method (r = 0.91, p < 0.001). Corradi et al. have dem-
onstrated that quantitative lung ultrasound, based on a
video gray scale analysis correlated withthe amount of
EVLW(59).Furthermore,thepleuraleffusioncouldbe
defined by the presence of anechoic or hypoechoic ho-
mogenous structure(60).InmoderatetosevereARDS,
the prevalence of cor-pulmonale diagnosed by trans-
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vel of PEEP. Bedside echocardiography can be used to
evaluate the right ventricular and biventricular cardiac
function.Duringperioperative period,wecanearlyde-
tect atelectasis by the presence of hyper echoic hepati-
zation suggesting the presence of consolidation. Furt-
hermore, the measurement of air column width of lar-
ynx during endotracheal cuff deflation is the good pre-
dictor of post-extubation laryngeal edema and may
predict post-operative intubation (61).
3. Protective ventilation
in non-injured lung
The beneficial effects of protective ventilation
with lower tidal volume and higher PEEPwere clearly
established by ARDS Network 15 years ago (62). Pro-
tective ventilation (PV) for non-injured lung has been
studied in a contest of ICU and perioperative period.
Lee et al. firstly studied the role of protective ven-
tilations in 103 ICU patients with non-injured lungs
(63). The main outcome of this study was the duration
of mechanical ventilation that was lower in patients
treated with protective ventilation (2.30 days vs. 3.90
days) (63). Gajic et al. evaluated the effect of PV in a
cohort study on 166 patients without lung injury and
admittedinICU(64).Theauthorsdidnotreportsignif-
icant differences in development of lung injury betwe-
enthegroups(64).Wolthuisetal.showedtheeffectsof
PV in lowering sedative use, as primary outcome, in
non-injured lung patients (65).Inthisstudy theauthors
did not find significant difference between the groups
(65). Yilmaz et al. performed a cohort study on 375
ICU patients to evaluate the role of PV on prevention
of lung injury as primary outcome (66). The authors
did not find difference between protective and conven-
tional ventilation about the considered outcome (66).
Determann et al. and Pinheiro de Oliveira et al.perfor-
medrandomized controlled trialstoassessthelevelsof
cytokine in broncho-alveolar lavage (BAL) in patient
treated with protective and conventional ventilation
(67, 68). Interestingly, Determann et al. did not show
any differences in cytokine in BAL, while Pinheiro de
Oliveira et al. demonstrated a higher level of Cytokine
in BAL in protective than in conservative ventilation
(168 pg/ml vs.72 pg/ml) (67, 68).
Protective ventilation was also studied in a perio-
perative setting on healthy lungs. It has been reported
that 5% to 10% of major abdominal and thoracic sur-
gery developed postoperative pulmonary complicati-
ons (69). Different randomized controlled trials (RCTs)
have been performed in major abdominal surgery on
PV with different outcomes. Determann et al. did not
find any differences in BAL and plasma inflammation
proteins between protective and conventional ventila-
tion (70). Wolthuis at el. reported a reduction in BAL
myeloperoxidase using PV in healthy patients under-
went abdominal surgery (70). Weingarten et al. experi-
enced a better oxygenations but no improvement of in-
flammatory biomarkers in a RCT on patients aged > 65
years (70). Treschan et al. evaluated the effectiveness of
PVin 101 healthy lung patients (71). In this study, there
was no difference in improving lung function between
protective and conventional ventilation (71). Recently,
Severgninietal.performedaRCTevaluatingtheroleof
PVin major abdominal surgery (10). The authors repor-
ted an improvement in pulmonary function and modi-
fied clinical pulmonary infection score (mCPIS) and a
reductioninX-raychestfindingsinpatientstreatedwith
PV during surgery (10). Futier et al. performed a large
RCTon 400 patients submitted to major abdominal sur-
gery with protective and conventional ventilation (9).
The authors found a reduced incidence of pulmonary
and extrapulmonary complications in PV group (9).
Protective ventilation was also matter of study in cardi-
ac surgeries. In coronary artery bypass surgery, three
studies did not demonstrate any difference in plasma
and BAL cytokine levels using PV (72, 73, 74). Sundar
et al. performed a RCT on PV in cardiac surgery on 149
patients (75). The authors found less incidence of re-in-
tubation and a faster weaning at 6–8 hours after surgery
in patients treated with PV )75).
Protective ventilation in non-injured lung was al-
so evaluated in different meta-analysis including ICU
and perioperative studies. In meta-analysis by Ser-
pa-Neto etal.,theauthors included 20studies, but only
15 RCT, and 2833 ICU and surgical patients (76). In
this meta-analysis, PV had a tidal volume of 6.5 ml/kg
and PEEP of 6.4 cm H2O while conventional ventila-
tion with tidal volume of 10.6 ml/kg and PEEP of 3.4
cm H2O. Among patients without lung injury, PV was
associated with better outcomes as acute lung injury
(RR 0.33; 95 %CI 0.23–0.47), pulmonary infection
(RR 0.52; 95 %CI 0.33–0.82), atelectasis (RR 0.62; 95
%CI 0.41–0.95) and mortality (RR 0.64; 95 %CI
0.46–0.86) (76). In the meta-analysis by Hemmes et
al., the authors included 8 studies. But 6 RCT, and 169
surgical patients without lung injury (77). PV was per-
formed with 6.1 ml/kg mean tidal volume and 6.6 cm
H2O PEEP while conventional ventilation with 10.4
ml/kg tidal volume and 2.7 cm H2O PEEP (77). In this
study PV protected against postoperative complicati-
ons as acute lung injury (RR 0.40; 95 % CI 0.22–0.70)
pulmonaryinfection(RR0.64;95%CI0.43–0.97)and
atelectasis(RR0.67;95%CI0.47–0.96) (77).Arecent
meta-analysis by Sutherasan et al. included 17 studies
as RCT and 1,362 ICU and surgical patients (78). In
this study PV was set with mean tidal volume of 6.1
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ventilation with mean tidal volume of 10.7 ml/kg and
PEEP of 2.5 cm H2O (78). This meta-analysis sugge-
sted that among surgical and critically ill patients with-
out lung injury, protective mechanical ventilation with
use of lower VT, with or without PEEP, is associated
with better clinical pulmonary outcomes in term of
ARDS incidence (RR 0.27; 95 % CI 0.12–0.59) and
pulmonary infection (RR 0.35; 95 % CI0.25–0.63) but
does not decrease atelectasis (RR 0.76; 95 % CI
0.33–1.37), mortality (RR 1.03; 95 % CI 0.67–1.58) or
length ofstay inICUorhospital (WMD–0.40; 95 %CI
–1.02; 0.22. WMD 0.13; 95 %CI –0.73; 0.08) (78).
4. Protective ventilation in ARDS
Protective ventilation is a supportive tool for pati-
ents with acute lung injury. In this setting, PV was ex-
tensively studied across the years. PV included low ti-
dalvolume, high PEEPand insomecircumstances rec-
ruitment maneuvers.
In the 1998, Amato et al. performed a multicenter
RCT to evaluate the effects of low tidal volume (6
ml/kg) on mortality, barotrauma and multiple organ fa-
ilure (MOF) in a cohort of ARDS patients (79). PV,
compared with conventional ventilation, was associa-
ted with improved survival at 28 days, higher rate of
weaning from mechanical ventilation, and lower rate
of barotrauma in patients with ARDS although it was
not associated with higher rate of survival to hospital
discharge(79).Brochard etal.andBroweretal.inpro-
spective RCTs evaluated the effect of low tidal volume
(7 ml/kg and 8 ml/kg) in ARDS patients in mortality,
duration of mechanical ventilation and barotraumas
(80, 81). Both studies concluded that there were no ef-
fects of PV on considered outcomes (80, 81). In the
2000, the ARDS network group performed a large
RCT including 861 adult ARDS patients to assess the
roleoflowtidalvolume(6m/kg)differentoutcomesas
mortality, MOF, duration of mechanical ventilation,
barotrauma and ventilator free days (62). In this study
the authors concluded that in ARDS patients mechani-
cal ventilation with a lower tidal volume, than is tradi-
tionally used, resulted in decreased mortality and in-
creases the number of days without ventilator use (62).
In the 2004, the ARDS network performed another
study to evaluate the effect of higher versus lower PE-
EP in ARDS patients on the same previous outcomes
(81). Inthis study,PVwassethigh PEEP5–25 cmH2O
according FiO2 while conventional ventilation with
low PEEP 5 cm H2O (82). This study found no differ-
ence in the considered outcome when high PEEPlevel
was compared with low PEEP (82). PV with high and
low PEEP levels was matter of study in three different
RCTs performed in 2008 (55, 83, 84). In the study by
Meade et al., high PEEPlevel was fixed between 5–25
cm H2O according FiO2 and low PEEP level at 5 cm
H2O (83). In the study by Mercat et al. high PEEP was
chosen according to Plateau pressure of28–30 cmH2O
and low PEEPbetween 5–9 cm H2O (84). Talmor et al.
fixed the high PEEP level at 17 cm H2O and the low
PEEPlevel at10cmH2O(55,29).Inthese studies high
PEEP did not affect mortality (55, 83, 84). Interest-
ingly, while Mercat et al. found an improvement in
lung function and a reduction of MOF and duration of
mechanical ventilation; Meade et al. did not confirm
thesefindings (83,84).Furthermore,theconclusion by
Talmor et al, was very interesting because the authors
suggested the use of mechanical ventilation guided by
esophageal pressure to further improve oxygenation
and compliance inARDSpatients (29).Recently ame-
ta-analysis evaluated theeffectsofhighversuslowPE-
EP in ARDS patients considering 7 RCTs and 2565
ARDS patients (15). The outcomes were mortality, ox-
ygenation, barotrauma and length of stay in ICU (15).
High PEEP did not affect mortality, barotrauma and
length of stay in ICU but improved the oxygenation of
ARDS patients at 1, 3 and 7 days (15).
5. Other adjunctive rescue
strategies for ARDS
5.1 Prone positioning
Prone position is the adjunctive treatment that can
improve oxygenation in 70% of patients. The mecha-
nisms are an increase in end-expiratory lung volume,
improvement of ventilation-perfusion matching and de-
crease of mass effect of the heart at the lower lobes as
well as an increased homogeneity of ventilation (11).
Recent randomized controlled trial has demonstra-
ted that in patients with PaO2/FiO2 less than 150 when
receiving FiO2 of 60%, patients who received prone po-
sition showed the decrease in mortality than in supine
position (28-day mortality; 16% vs. 32.8%, respecti-
vely) (85). Moreover, recent meta-analysis including
this RCT have demonstrated that prone position with
low tidal volume ventilation in severe ARDS patients
significantly decrease 60-day mortality (86). In the sub-
groupwhichthedurationofpronepositioningwasmore
than 10 hours per session showed markedly reduced in
overall mortality compared with the shorter duration
groups(87).However,theriskofpressureulcerandma-
jor airways problems should be considered during im-
plementing the prone positioning protocol (87).
5.2 Extracorporeal membrane
oxygenation
Extracorporeal membrane oxygenation (ECMO)
have shown the increase of survival in severe ARDS
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furtherVALIinARDSandcomplications fromECMO
itself, another approach is bridging MV with extracor-
poreal membrane oxygenation. During applying EC-
MO, the VT can be decreased until less than 6 ml/kg
PBW (“ultra” protective MV) (85).
Strategies for prevention and management pati-
entswithARDSandwithout ARDSaresummarized in
Table 1.
6. Methods for prevention
of ventilator associated lung injury
and postoperative pulmonary
complications
6.1 Risk factors for ARDS
and ventilator associated lung injury
In severe sepsis patients present at emergency de-
partment, high lactate, lung injury prediction scores
and microbiological proven infection are independent
risk factors for the development of ARDS (88). Other
factors i.e. hypoalbuminemia, chemotherapy, obesity
and diabetic mellitus have been proposed as the risk
factors of ARDS. Gajic el al have validated lung injury
prediction score (LIPS) to identify the high risk pati-
ents at the time of hospital admission and can discrimi-
nate the patients who developed ARDS from those
who did not with an AUC of ROC at 0.80 (95%CI;
0.78–0.82) (89). The variables that were included in
calculated worksheet composed of previously mentio-
ned factors, type of surgery and trauma.
Severalfactorshavebeenprovenasthepredispos-
ing factors of VALI i.e. sepsis, fluid loading, blood
transfusion and age. Old animals are more susceptible
to VALI with high VT and constant PEEP compared
with younger animals associated with the increase
amount oflung lavage protein, IL-6concentration, and
increase of lung wet to dry ratios (90). Transfusion-re-
lated acute lung injury (TRALI) is the reaction of the
PROTECTIVE MECHANICAL VENTILATION IN PATIENTS WITHOUT OR WITH LUNG INJURY 77
Table 1. Strategies for prevention and management patients with ARDS and without ARDS
Patients with ARDS Patients without ARDS in ICU
Patients undergoing high risk
surgery i.e. intra-abdominal
surgery
Risk factors for further VALI
and postoperative pulmonary
complications
– Sepsis
– Fluid loading
– Blood transfusion
– Old age
– Underlying status
– Type of anaesthesia
– Type of surgery i.e. cardio-
pulmonary surgery and
abdominal surgery
– Smoking status
Protective ventilation – Tidal volume 6 ml/kg PBW
– Plateau pressure = 30 cmH2O
– PEEP according to PEEP/FiO2
table or titration by respiratory
mechanics and/or oesophageal
pressure
– Recruitment maneuver
– Tidal volume 6–8 ml/kg PBW
– Plateau pressure < 20 cm H2O
– PEEP of 6–8 cm H2O
– Recruitment maneuver every 30
minutes
Oesophageal pressure monitoring – Obesity, pleural effusion,
intra-abdominal hypertension,
ARDS, massive ascites
– High risk abdominal surgery,
obesity
Other effective strategies – Prone position when
PaO2/FiO2 < 150 mmHg and
PEEP >10 cm H2O
– Extracorporeal membrane
oxygenation
– Neuromuscular blocking agents
– Perioperative physiotherapy
– Noninvasive ventialtion
Predictive scores LIPS score ARISCAT, SLIP, PRF and
SPORC
Abbreviations: ARDS: Acute Respiratory Distress Syndrome; ICU: intensive care unit; VALI: ventilator associated lung injury;
PEEP:positive endexpiratory pressure;PBW:Predicted bodyweight; LIPS:lunginjuryprediction score;PRF:postoperative respi-
ratory failure index; ARISCAT: Postoperative pulmonary complications risk score; SLIP: Surgical lung injury prediction score;
SPORC: Score for Prediction of Postoperative Respiratory Complicationstransfusion of antibodies against the recipients’ anti-
genthat accumulate during blood storage whichaggra-
vate lung injury. TRALI combined with injurious MV
setting may aggravate further lung injury, particularly
transfusion blood with longer storage duration in sep-
tic patients (91).
6.2 Role of recent predictive scores
PPCs are associated with various risk factors na-
mely underlying status, type of anaesthesia and sur-
geryparticularly cardiopulmonary surgeryandabdom-
inal surgery as well as smoking status.
Several investigators have developed different
scores to predict the risk of PPCs. The parameters re-
quiredforscorecalculation canbeassessedpreoperati-
vely and during bedside evaluation.
6.2.1 Post-operative respiratory
failure risk index and pneumonia
risk index
Based on National Surgical Quality Improvement
Program (NSQIP) data, postoperative respiratory fail-
ure (PRF) index was developed by the investigators
from veterans’ affair in non-cardiac surgery patients.
The risk factors were including the type of surgery,
age, functional status and COPD. The laboratory data
comprised albumin level less than 30 g/L, and blood
urea nitrogen level more than 30 mg/dL in the model
(92). The same group has constructed another index,
postoperative pneumonia risk index that are added the
dataofimpairedsensorium,cerebralvascularaccident,
transfusion, long-term steroid use, smoking, and alco-
hol use to previously mentioned index (93). These in-
dexeshavealimitation thatthemajorityofpopulations
included in the analysis are male veterans therefore
these indexes may not be used generalizability.
6.2.2 Postoperative pulmonary
complications risk score
(ARISCAT score)
Canet et al. have identified the seven independent
risk factors including low pre-operative arterial oxy-
gen saturation, recent acute respiratory infection, age,
anemia, upper abdominal or intra thoracic surgery, sur-
gical duration of at least 2 h, and emergency surgery
and showed that the AUCs under ROC curve of this
score are 90% for the development of PPCs predictive
index and 80% from the validation of this index (53).
The PERISCOPE (Prospective Evaluation of a Risk
Score for Postoperative Pulmonary Complications in
Europe) study is completed and will show the data of
external validation of this score (94).
6.2.3 Surgical lung injury prediction
score (SLIPscore)
The surgical lung injury prediction score (the
SLIP score) were developed to classify the patients
who at risk for postoperative ARDS in patients with
high-risk surgery and require mechanical ventilation
during general anaesthesia forlonger than 3hours with
an AUC of 0.82 (95% CI 0.78–0.86). The score inclu-
des diabetes, COPD, GERD, alcohol abuse and type of
surgery. However, this study is conducted in single
centre and retrospective study (95).
6.2.4 Score for Prediction
of Postoperative Respiratory
Complications (SPORC)
Another recent score that developed to predict po-
stoperative re-intubation is Score for Prediction of Post-
operative Respiratory Complications (SPORC) within
the first 3 postoperative days. Four independent predic-
tors contribute to an American Society of Anesthesiolo-
gists(ASA)score 3:emergencysurgery,high-risksur-
gical service, history of congestive heart failure and
chronic pulmonary disease (96).
CONCLUSION
Protective ventilation has been proven preventing
further complications i.e. VALI, postoperative pulmo-
nary complications in either ARDS or non-injured
lungs. Predictive scores and bedside respiratory moni-
toring i.e. ultrasound and esophageal pressure measu-
rement are crucial tools to identify at risk patients and
minimize further VALI as well as PPCs.
Abbreviations
AECC — American–European Consensus Con-
ference
PPCs—Postoperativepulmonarycomplications
ARDS — Acute Respiratory Distress Syndrome
VALI — Ventilator associated lung injury
PEEP— Positive end expiratory pressure
ICU — Intensive care unit
MV — Mechanical ventilation
PL— Transpulmonary pressure
VT — Tidal volume
TLRs — Toll-like receptors
NF-kappaB — Nuclear factor kappa B
TNF — Tumor necrosis factor
IL— Interleukins
ECM — Extracellular matrix
Pplat — Plateau pressure
FRC — Functional residual capacity
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Ecw — Chest wall elastance
EL— Lung elastance
ERS — Respiratory system elastance
PL— Transpulmonary pressure
Paw — Mean airway pressure
Pcw — Pressure difference across the chest wall
EVLW — Extravascular lung water
PV — Protective ventilation
BAL— Broncho-alveolar lavage
RCTs — Randomized controlled trials
mCPIS — Modified clinical pulmonary infection
score
MOF — Multiple organ failure
ECMO—Extracorporealmembraneoxygenation
LIPS — Lung injury prediction score
TRALI — Transfusion-related acute lung injury
NSQIP — National Surgical Quality Improve-
ment Program
PRF — Postoperative respiratory failure
the SLIPscore — Surgical lung injury prediction
score
SPORC — Score for Prediction of Postoperative
Respiratory Complications
ASA— American Society of Anesthesiologists
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Smrtnost od Sindroma Akutnog Respiratornog Dis-
tresa(ARDS)jejo{uvekvisokaikre}eseod27do45%
prema Berlinskoj definiciji. ^ak i kod hirur{kih pacije-
nata bez povrede plu}a, postoperativne plu}ne kompli-
kacije (PPC) su ~este. Kod ARDS-a, protektivna venti-
lacija sa niskim „tidal“ volumenom od 6 ml/kg PBW i
vi{im nivoima pozitivnog end-ekspiratornog pritiska
(PEEP) su {iroko prihva}eni kao rutinska praksa. Kod
pacijenata bez ARDS-a, podvrgnutih mehani~koj venti-
laciji, protektivna ventilacija sa niskim „tidal“ volume-
nom od 6 ml/kg PBW i niskim do srednjim PEEPom su
postali nov izazov suportivne nege posebno u jedinica-
ma intenzivne nege i kod perioperativnih pacijenata.
Respiratorni monitorig je od velike pomo}i za pode{a-
vanje optimalne ventilacije kako bi se prevenirala po-
vrede usled asistirane ventilacije i na vreme detektovale
postoperativne plu}ne komplikacije u perioperativnom
periodu. Nekoliko rezultata je usvojeno kako bi se sma-
njio rizik od ARDS, PPC i VALI (ventilator associated
lunginjury).Vremejezaprimenubazi~nefiziologijere-
spiratorne funkcije i na dokazima zasnovane prakse ka-
ko bi se unapredili ishodi ARDS-a i PPC.
Klju~ne re~i: asistirana ventilacija, Akutni Respi-
ratorni Distres Sindrom, transpulmonarni pritisak, Po-
sitivni End Ekspiratorni Pritisak, Protektivna ventila-
cija, Respiratorni monitoring.
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